Heron Therapeutics, Inc. (HRTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$0.2942+$0.0042 (+1.45%) on the dayAs of the close; data may be delayed.
HRTX price, last 12 months
Key stats
- Previous close
- $0.2900
- Open
- $0.2900
- Day range
- $0.2800 – $0.3000
- 52-week range
- $0.2610 – $1.58
- Volume
- 1.6M
- Avg volume (20 days)
- 2.1M
- Market cap
- $55.9M
Performance
1W−5.0%
1M−5.8%
3M−31.6%
6M−64.3%
YTD−77.4%
1Y−76.5%
vs S&P 500, 1Y−93.2 pts
Technicals and fundamentals
About Heron Therapeutics, Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $55.9M